Intrapartum Hemorrhage

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Intrapartum Hemorrhage trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06655207

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification…

Oli is a predictive, non-invasive device, intended to be placed on the participant's maternal abdomen during the intrapartum period, which can alert healthcare…

United States1,000 participantsStarted 2025-08-06

Treatment: Oli is a non-invasive, wearable device, designed to provide clinicians with an early indication if the participant is at a higher risk of developing abnormal postpartum uterine bleeding

All recent trials (16 shown)

Not Yet RecruitingPhase 2

NCT07550413

Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section

To determine the effectiveness of prophylactic intravenous calcium chloride administered after cord clamping in reducing postpartum blood loss during intrapartu…

Pakistan182 participantsStarted 2026-05

Treatment: Calcium Chloride, Placebo

Not Yet RecruitingNot Applicable

NCT07318467

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primar…

While Carbetocin is effective in reducing PPH, the combination of oxytocin, Tranexamic acid, and Ergot derivatives may offer additional benefits in high-risk po…

Location not specified80 participantsStarted 2026-01-01

Treatment: Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative, Intravenous Carbetocin alone

Intrapartum Hemorrhage

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification…

All recent trials (16 shown)

Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primar…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification…

All recent trials (16 shown)

Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primar…

Exteriorization Versus Non-exteriorization of the Uterus During Repair of Uterine Incision in a Repeated Cesarean Sectio…

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

World Maternal Antifibrinolytic Trial_2

Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Ou…

Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities

A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage

A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss

Prostaglandins Before Caserean Section

Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss

Control of Blood Loss During Caesarean Section

The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caes…

Thromboelastography in Non-elective Cesarean Delivery